Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches.
D000109:Acetylcholine / Q000378:metabolism; D003894:Deamino Arginine Vasopressin / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism; D006801:Humans; D009074:Melanocyte-Stimulating Hormones / Q000378:metabolism; D019964:Mood Disorders / Q000378:metabolism / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D011957:Receptors, Opioid / Q000502:physiology; D012701:Serotonin / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism
D018377:Neurotransmitter Agents; D011957:Receptors, Opioid; D012701:Serotonin; D007987:Gonadotropin-Releasing Hormone; D013973:Thyrotropin-Releasing Hormone; D009074:Melanocyte-Stimulating Hormones; D003894:Deamino Arginine Vasopressin; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine